Understanding how buprenorphine affects dental health in patients with opioid use disorders
Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries
This study is looking at how buprenorphine, a medication for opioid use disorder, affects dental health, especially since some patients have reported dental problems while using it, and the goal is to find ways to help improve their oral health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10765181 on NIH RePORTER |
What this research studies
This research investigates the effects of buprenorphine, a medication used to treat opioid use disorders, on dental health, particularly focusing on its high concentrations in oral fluids after sublingual administration. The study aims to uncover the mechanisms behind the dental damage reported by patients using buprenorphine, which has been linked to serious oral health issues. By analyzing the relationship between buprenorphine exposure and dental caries, the research seeks to identify potential pharmacological solutions to mitigate these side effects. Patients who take buprenorphine may be directly impacted by the findings, as the research aims to improve their overall quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing treatment for opioid use disorders who are prescribed buprenorphine in sublingual forms.
Not a fit: Patients not using buprenorphine or those with dental issues unrelated to medication use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved dental health outcomes for patients using buprenorphine, enhancing their quality of life.
How similar studies have performed: While the specific mechanisms of buprenorphine's effects on dental health are not well-studied, similar research on opioid medications has shown potential for uncovering significant health impacts.
Where this research is happening
Houston, United States
- University of Houston — Houston, United States (Active)
Researchers
- Principal investigator: Hu, Ming — University of Houston
- Study coordinator: Hu, Ming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.